Johnson J P, Demmer-Dieckmann M, Meo T, Hadam M R, Riethmüller G
Eur J Immunol. 1981 Oct;11(10):825-31. doi: 10.1002/eji.1830111015.
Monoclonal antibodies were produced against melanoma cell lines derived from patients presently disease free. Based on tissue distribution of binding, the antibodies obtained could be used to classify melanoma surface antigens into groupings similar to those obtained from studies of autologous and xenogeneic antibodies. Three antibodies (21.43, 15.75 and 15.95) reacted with the immunizing tumor but not with peripheral blood lymphocytes or a lymphoblastoid cell line derived from the tumor donor. When tested on a broader cell panel, antibody 21.43 reacted only with melanoma lines, while antibodies 15.75 and 15.95 reacted with carcinoma cell lines as well as with the majority of melanoma cell lines. Antibody 15.95 precipitated a 49000 dalton glycoprotein from both melanoma and carcinoma cells. Antibody 15.75 precipitated a 74000 dalton glycoprotein from the surface of melanoma and carcinoma cell lines which is also found on freshly isolated tumor cells from melanoma and carcinoma metastases in vivo.
制备了针对源自目前无病患者的黑色素瘤细胞系的单克隆抗体。根据结合的组织分布情况,所获得的抗体可用于将黑色素瘤表面抗原分类,其分组类似于从自体和异种抗体研究中获得的分组。三种抗体(21.43、15.75和15.95)与免疫肿瘤发生反应,但不与外周血淋巴细胞或源自肿瘤供体的淋巴母细胞系发生反应。当在更广泛的细胞组上进行测试时,抗体21.43仅与黑色素瘤细胞系发生反应,而抗体15.75和15.95与癌细胞系以及大多数黑色素瘤细胞系发生反应。抗体15.95从黑色素瘤细胞和癌细胞中沉淀出一种49000道尔顿的糖蛋白。抗体15.75从黑色素瘤和癌细胞系表面沉淀出一种74000道尔顿的糖蛋白,在体内从黑色素瘤和癌转移灶新鲜分离的肿瘤细胞上也能发现这种糖蛋白。